Works matching IS 20445385 AND DT 2021 AND VI 11 AND IP 10

Results: 13

A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.

Published in:

2021

By:

Zeidner, Joshua F.;
Lin, Tara L.;
Vigil, Carlos E.;
Fine, Gil;
Yair Levy, M.;
Nazha, Aziz;
Esteve, Jordi;
Lee, Daniel J.;
Yee, Karen;
Dalovisio, Andrew;
Wang, Eunice S.;
Bergua Burgues, Juan M.;
Schriber, Jeffrey;
Litzow, Mark R.;
Frankfurt, Olga;
Castillo, Teresa Bernal Del;
Bhatt, Vijaya Raj;
Bhatnagar, Bhavana;
Mehta, Priyanka;
Dillon, Richard

Publication type:

Letter

Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study.

Published in:

2021

By:

Locatelli, Franco;
Zugmaier, Gerhard;
Mergen, Noemi;
Bader, Peter;
Jeha, Sima;
Schlegel, Paul-Gerhardt;
Bourquin, Jean-Pierre;
Handgretinger, Rupert;
Brethon, Benoit;
Rossig, Claudia;
Chen-Santel, Christiane

Publication type:

Correction Notice

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.

Published in:

2021

By:

Wei, Andrew H.;
Panayiotidis, Panayiotis;
Montesinos, Pau;
Laribi, Kamel;
Ivanov, Vladimir;
Kim, Inho;
Novak, Jan;
Stevens, Don A.;
Fiedler, Walter;
Pagoni, Maria;
Bergeron, Julie;
Ting, Stephen B.;
Hou, Jing-Zhou;
Anagnostopoulos, Achilles;
McDonald, Andrew;
Murthy, Vidhya;
Yamauchi, Takahiro;
Wang, Jianxiang;
Chyla, Brenda;
Sun, Yan

Publication type:

Correction Notice

Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths.

Published in:

2021

By:

Mangaonkar, Abhishek A.;
Ferrer, Alejandro;
Vairo, Filippo Pinto E.;
Hammel, Caleb W.;
Prochnow, Carri;
Gangat, Naseema;
Hogan, William J.;
Litzow, Mark R.;
Peters, Steve G.;
Scott, J. P.;
Utz, James P.;
Baqir, Misbah;
Carmona-Porquera, Eva M.;
Kalra, Sanjay;
Sekiguchi, Hiroshi;
Khan, Shakila P.;
Simonetto, Douglas A.;
Klee, Eric W.;
Kamath, Patrick S.;
Roden, Anja C.

Publication type:

Letter

Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy.

Published in:

2021

By:

Wang, Di;
Mao, Xia;
Que, Yimei;
Xu, Menglei;
Cheng, Yuhang;
Huang, Liang;
Wang, Jue;
Xiao, Yi;
Wang, Wen;
Hu, Guang;
Zhang, Shangkun;
Zhang, Tongcun;
Li, Chunrui;
Zhou, Jianfeng

Publication type:

Letter

Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma.

Published in:

2021

By:

Hulin, Cyrille;
Beksac, Meral;
Goodman, Hugh J.;
Spicka, Ivan;
Alegre, Adrian;
Prince, Miles;
Campana, Frank;
Finn, Greg;
Le-Guennec, Solenn;
Macé, Sandrine;
Muccio, Stéphane;
Tavernier, Alexandra;
Rouchon, Marie-Claude;
Richardson, Paul G.

Publication type:

Letter

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants.

Published in:

2021

By:

Cicconi, Laura;
Testi, Anna Maria;
Montesinos, Pau;
Rego, Eduardo;
Zhu, Hong Hu;
Takahashi, Hiroyuki;
Dworzak, Michael;
Estey, Elihu;
Schwarer, Anthony;
Esteve, Jordi;
Annibali, Ombretta;
Castelli, Roberto;
Mirabile, Milena;
Angelini, Mario;
Lazarevic, Vladimir;
Kumar, Jeevan;
Avvisati, Giuseppe;
Gurnari, Carmelo;
Locatelli, Franco;
Voso, Maria Teresa

Publication type:

Letter

Lifestyle considerations in multiple myeloma.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00560-x

By:

Shapiro, Yael N.;
Peppercorn, Jeffrey M.;
Yee, Andrew J.;
Branagan, Andrew R.;
Raje, Noopur S.;
Donnell, Elizabeth K. O'

Publication type:

Article

Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applications.

Published in:

2021

By:

Ohguchi, Hiroto;
Hideshima, Teru;
Anderson, Kenneth C.

Publication type:

Correction Notice

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00558-5

By:

Rautenberg, Christina;
Stölzel, Friedrich;
Röllig, Christoph;
Stelljes, Matthias;
Gaidzik, Verena;
Lauseker, Michael;
Kriege, Oliver;
Verbeek, Mareike;
Unglaub, Julia Marie;
Thol, Felicitas;
Krause, Stefan W.;
Hänel, Mathias;
Neuerburg, Charlotte;
Vucinic, Vladan;
Jehn, Christian-Friedrich;
Severmann, Julia;
Wass, Maxi;
Fransecky, Lars;
Chemnitz, Jens;
Holtick, Udo

Publication type:

Article

Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00556-7

By:

Kajüter, Hiltraud;
Wellmann, Ina;
Khil, Laura;
Jöckel, Karl-Heinz;
Zhang, Can;
Fink, Anna-Maria;
Hallek, Michael;
Stang, Andreas

Publication type:

Article

6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00555-8

By:

Wei, Andrew H.;
Panayiotidis, Panayiotis;
Montesinos, Pau;
Laribi, Kamel;
Ivanov, Vladimir;
Kim, Inho;
Novak, Jan;
Stevens, Don A.;
Fiedler, Walter;
Pagoni, Maria;
Bergeron, Julie;
Ting, Stephen B.;
Hou, Jing-Zhou;
Anagnostopoulos, Achilles;
McDonald, Andrew;
Murthy, Vidhya;
Yamauchi, Takahiro;
Wang, Jianxiang;
Chyla, Brenda;
Sun, Yan

Publication type:

Article

Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00554-9

By:

Talluri, Srikanth;
Samur, Mehmet K.;
Buon, Leutz;
Kumar, Subodh;
Potluri, Lakshmi B.;
Shi, Jialan;
Prabhala, Rao H.;
Shammas, Masood A.;
Munshi, Nikhil C.

Publication type:

Article